Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation (RFTA), and sorafenib. Tumor lysis syndrome induced by low-dose steroid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Mol Hepatol
Main Authors: Kim, Jin Ok, Jun, Dae Won, Tae, Hye Jin, Lee, Kang Nyeong, Lee, Hang Lak, Lee, Oh Young, Choi, Ho Soon, Yoon, Byung Chul, Hahm, Joon Soo
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379202/
https://ncbi.nlm.nih.gov/pubmed/25834806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.21.1.85
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados